Social Determinants of Health and Cerebral Small Vessel Disease: Is Epigenetics a Key Mediator?
Journal of the American Heart Association · 04.07.2023 · 12 (13)
DOI: 10.1161/jaha.123.029862 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 04.07.2023. Verfasst von Livia Parodi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Medicine Massachusetts General Hospital Boston MA USA. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Stroke, Cognitive Dysfunction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Cerebral small vessel disease is highly prevalent, particularly in marginalized communities, and its incidence is expected to increase given the aging global population. Cerebral small vessel disease contributes to risk for stroke, vascular cognitive impairment and dementia, late‐life depression, and gait disorders. A growing body of evidence suggests that adverse outcomes, including cerebral small vessel disease, caused by traditional cardiovascular risk factors are at least partly mediated by epigenetic changes, some of them already beginning during fetal development. Societal and health care access inequities, summarized under the umbrella term social determinants of health, put a higher burden of cardiovascular risk factors on marginalized populations and expose them to an increased risk for adverse outcomes. Social epigenetics has begun to deliver solid evidence that social determinants of health lead to distinct epigenetic signatures that potentially mediate the biological effect of environmental exposures on cardiovascular risk factors. Here, we provide a review of the most recent advances in the epigenetics of cerebral small vessel disease risk factors and social determinants of health and call for research efforts combining insights from both fields to reach a deeper understanding of the causal pathways, ultimately facilitating discovery of new treatment targets for a disease whose burden is magnified by existing health disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Genomic Medicine Massachusetts General Hospital Boston MA USA.
- The Broad Institute of Harvard and MIT Cambridge MA USA.
- Henry and Allison McCance Center for Brain Health Massachusetts General Hospital Boston MA USA.
- Department of Neurology Brigham and Women's Hospital Boston MA USA.
- Department of Biostatistics and Data Science, Division of Public Health Sciences Wake Forest University School of Medicine Winston-Salem NC USA.
- Center for Precision Medicine Wake Forest University School of Medicine Winston-Salem NC USA.
ORCID-Profile: Livia Parodi, Ernst Mayerhofer, Kaavya Narasimhalu, Nirupama Yechoor, Mary E Comeau, Jonathan Rosand, Christopher D Anderson
Förderung
- NINDS NIH HHS
Zitieren
APA
Parodi, L., Mayerhofer, E., Narasimhalu, K., Yechoor, N., Comeau, M. E., Rosand, J., Langefeld, C. D., & Anderson, C. D. (2023). Social Determinants of Health and Cerebral Small Vessel Disease: Is Epigenetics a Key Mediator?. Journal of the American Heart Association, 12(13). https://doi.org/10.1161/jaha.123.029862
Vancouver
Parodi L, Mayerhofer E, Narasimhalu K, Yechoor N, Comeau ME, Rosand J, et al. Social Determinants of Health and Cerebral Small Vessel Disease: Is Epigenetics a Key Mediator?. Journal of the American Heart Association. 2023;12(13). doi:10.1161/jaha.123.029862
BibTeX
@article{Parodi2023,
author = {Parodi, Livia and Mayerhofer, Ernst and Narasimhalu, Kaavya and Yechoor, Nirupama and Comeau, Mary E and Rosand, Jonathan and Langefeld, Carl D and Anderson, Christopher D},
title = {Social Determinants of Health and Cerebral Small Vessel Disease: Is Epigenetics a Key Mediator?},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {13},
doi = {10.1161/jaha.123.029862}
}
EUVIMED